A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease. For patients with localized PDAC, surgery is the best option, but with a median survival of less than 2 years and a difficult and prolonged postoperative course for most, there is an urgent need to better identify patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stratford, Jeran K., Bentrem, David J., Anderson, Judy M., Fan, Cheng, Volmar, Keith A., Marron, J. S., Routh, Elizabeth D., Caskey, Laura S., Samuel, Jonathan C., Der, Channing J., Thorne, Leigh B., Calvo, Benjamin F., Kim, Hong Jin, Talamonti, Mark S., Iacobuzio-Donahue, Christine A., Hollingsworth, Michael A., Perou, Charles M., Yeh, Jen Jen
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903589/
https://ncbi.nlm.nih.gov/pubmed/20644708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1000307
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados